Search
for
Sort by
Research 91–120 of 211
- Alopecia areata in atopic dermatitis: coincidence or regularity?
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- 772 Alopecia areata shares OX40 activation and Th1 and Th2 increases across atopic backgrounds
- The JAK/STAT signaling pathway: from bench to clinic
- The microbiome in patients with atopic dermatitis
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- Natural killer cells in atopic and autoimmune diseases of the skin
- Understanding autoimmunity of vitiligo and alopecia areata
- Local heroes or villains: tissue-resident memory T cells in human health and disease
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Alopecia Areata: Current Treatments and New Directions
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Frontiers in alopecia areata pathobiology research
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- Drug-induced alopecia after dupilumab therapy
- New and Emerging Therapies for Alopecia Areata
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Metabolic Syndrome and Skin Diseases
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- Oxidative Stress and Skin Diseases: The Role of Lipid Peroxidation